Insulin Start Therapy Application With Resources and Training

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

I-START

Designed as a supplementary educational tool for patients on insulin therapy, I-START includes an injection plan to reinforce the knowledge and behaviors that users have been taught by their health care provider. This is done through eight modules created for the benefit of new and experienced insulin users, and those using pens or vial/syringes. The modules address a variety of topics pertinent to insulin therapy, including overcoming psychosocial barriers, injection techniques and best practices, managing hypo- and hyperglycemic events, monitoring blood glucose and troubleshooting and problem solving. At the end of each module, users can self-evaluate their confidence in mastering the information presented. This gives them the ability to move forward into the next module, repeat material already presented and/or save features of the modules that they would like to revisit at another time.

BEHAVIORAL

Standard Insulin Administration Education

Standard best practices for training patients to administer insulin therapy include 1) a thorough patient assessment prior to therapy initiation to address barriers, including evaluation for diminished cognitive capacity or other problem that may impair safe insulin self-administration, and assessment of health literacy and numeracy skills; 2) observation of a patient's injection practice, with re-education provided as needed; 3) use of appropriate language is necessary when teaching injection technique; 4) dose preparation, which includes inspecting the insulin dose for accuracy (following manufacturer instructions); and 5) review of signs, symptoms and treatment of hypoglycemia must be included as a critical component of the training.

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT03999268 - Insulin Start Therapy Application With Resources and Training | Biotech Hunter | Biotech Hunter